PT-141 represents a cutting-edge cyclic melanocortin agonist that demonstrates potential in the treatment of sexual dysfunction. This novel compound acts by enhancing specific receptors within the body, causing to enhanced sexual response. Preclinical studies have revealed that PT-141 may effectively manage a spectrum of sexual dysfunctions in bot